Forte Capital LLC ADV Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Forte Capital LLC ADV grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,203 shares of the healthcare conglomerate’s stock after acquiring an additional 44 shares during the period. Forte Capital LLC ADV’s holdings in UnitedHealth Group were worth $1,160,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. International Assets Investment Management LLC raised its position in shares of UnitedHealth Group by 53,573.1% in the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate’s stock worth $1,238,515,000 after purchasing an additional 2,348,107 shares during the last quarter. Jennison Associates LLC lifted its stake in shares of UnitedHealth Group by 49.3% in the fourth quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate’s stock worth $1,904,670,000 after buying an additional 1,195,352 shares in the last quarter. Mawer Investment Management Ltd. increased its position in shares of UnitedHealth Group by 75.0% during the third quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate’s stock valued at $1,014,002,000 after acquiring an additional 862,024 shares in the last quarter. California Public Employees Retirement System boosted its stake in UnitedHealth Group by 35.9% during the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate’s stock valued at $1,627,311,000 after purchasing an additional 815,822 shares during the last quarter. Finally, Ameriprise Financial Inc. raised its stake in shares of UnitedHealth Group by 20.1% in the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock worth $1,879,245,000 after purchasing an additional 623,631 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on UNH. Stephens reiterated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Royal Bank of Canada cut their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Barclays raised their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Finally, StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Stock Down 0.1 %

UNH stock traded down $0.52 during trading on Friday, hitting $492.45. 2,487,811 shares of the company’s stock traded hands, compared to its average volume of 5,130,659. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $453.09 billion, a P/E ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. The business has a fifty day simple moving average of $482.32 and a two-hundred day simple moving average of $512.76. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The company had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the company posted $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.